Skip to content
Clinical Trials – home
The NetherlandsBack to the Netherlands

Clinical trials in S-Hertogenbosch – page 11

147 clinical trials in S-Hertogenbosch, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
S-Hertogenbosch at a glance
147
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

147 trials in S-Hertogenbosch

Open in trial search
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Eli Lilly & Co.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Selpercatinib
  • Sponsor:Eli Lilly & Co.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen - Cilag International

Atrial fibrillation+3

Not recruiting
Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Rijnstate Ziekenhuis Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dextrose Bp
  • Sponsor:AstraZeneca AB
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne
Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Nalbuphine Hydrochloride
  • Sponsor:Trevi Therapeutics Inc.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Florquinitau (18F)
  • Sponsor:Alector LLC

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in S-Hertogenbosch

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on acute myeloid leukemia and chronic lymphocytic leukemia, evaluating innovative combination therapies and treatment approaches. Studies also include investigations into advanced breast cancer treatments and novel therapies for small cell lung cancer.

  • Blood Cancers
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer

Several trials are exploring targeted therapies and immunotherapy combinations to improve patient outcomes.

02 Cardiovascular Studies

Research initiatives examining heart failure prevention and stroke management, including studies on new therapeutic combinations and preventive treatments for cardiovascular events.

  • Heart Failure Prevention
  • Stroke Management
  • Cardiovascular Risk

Focus on developing innovative treatments to reduce cardiovascular mortality and improve patient outcomes.

03 Neurological Disorders

Clinical investigations targeting Alzheimer's disease, evaluating new therapeutic approaches for both mild cognitive impairment and dementia. Studies aim to improve cognitive function and quality of life.

  • Alzheimer's Disease
  • Cognitive Function
  • Dementia Treatment

Trials explore novel drug combinations and treatment strategies for neurodegenerative conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.